Provided herein are pharmaceutical compositions comprising a therapeutically effective amount of albuterol and a therapeutically effective amount of hypertonic saline. Also provided here are methods of using the aforementioned pharmaceutical compositions to treat one or more symptoms of obstructive airway diseases.